Advertisement

Neurological Sciences

, Volume 38, Supplement 1, pp 111–115 | Cite as

Ketogenic diet in migraine: rationale, findings and perspectives

  • Piero Barbanti
  • Luisa Fofi
  • Cinzia Aurilia
  • Gabriella Egeo
  • Massimiliano Caprio
Symposium - Nutraceutics and Headache

Abstract

Ketogenic diet (KD) is an established treatment for refractory pediatric epilepsy and a promising therapy for diverse neurological diseases. Clinical data on KD in migraine—obtained from 150 patients investigated in case reports and prospective studies—suggest that KD may be a rapid onset effective prophylaxis for episodic and chronic migraine. KD would contribute to restore brain excitability and metabolism and to counteract neuroinflammation in migraine, although its precise mechanism is still unclear. Randomized controlled studies are needed to confirm the usefulness of KD in migraine and to investigate its optimal duration, repeatability, feasibility in normal weight subjects, efficacy in pediatric population and association to conventional migraine prophylaxis.

Keywords

Migraine Ketogenic diet Treatment Prevention Disability 

Notes

Compliance with ethical standards

Conflict of interest

I certify that there is no actual or potential conflict of interest in relation to this article.

References

  1. 1.
    Martin VT, Vij B (2016) Diet and headache: part 2. Headache 56(9):1553–1562CrossRefPubMedGoogle Scholar
  2. 2.
    Paoli A, Rubini A, Volek JS, Grimaldi KA (2013) Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr 67(8):789–796CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine–current understanding and treatment. N Engl J Med 346(4):257–270CrossRefPubMedGoogle Scholar
  4. 4.
    Guelpa G, Marie A (1911) La lutte contre l’epilepsie par la disintoxication et par la reeducation alimentaire. Rev Ther Med Chir 78:8–13Google Scholar
  5. 5.
    Stafstrom CE, Rho JM (2012) The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 3(59):1–8Google Scholar
  6. 6.
    Martin K, Jackson CF, Levy RG, Cooper PN (2016) Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev 2:CD001903. doi: 10.1002/14651858 PubMedGoogle Scholar
  7. 7.
    Vanitallie TB, Nonas C, Di Rocco A et al (2005) Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 64(4):728–730CrossRefPubMedGoogle Scholar
  8. 8.
    Henderson ST, Vogel JL, Barr LJ et al (2009) Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab 6:31. doi: 10.1186/1743-7075-6-31 CrossRefGoogle Scholar
  9. 9.
    Woolf EC, Syed N, Scheck AC (2016) Tumor metabolism, the ketogenic diet and β-hydroxybutyrate: novel approaches to adjuvant brain tumor therapy. Front Mol Neurosci 9(122):1–11Google Scholar
  10. 10.
    Evangeliou A, Vlachonikolis I, Mihailidou H et al (2003) Application of a ketogenic diet in children with autistic behavior: pilot study. J Child Neurol 18:113–118CrossRefPubMedGoogle Scholar
  11. 11.
    Vecchia D, Pietrobon D (2008) Migraine: a disorder of brain excitatory–inhibitory balance? Trends Neurosci 8:507–520Google Scholar
  12. 12.
    Montagna P, Cortelli P, Monari L et al (2004) 31P-magnetic resonance spectroscopy in migraine without aura. Neurology 44(4):666–669CrossRefGoogle Scholar
  13. 13.
    de Almeida Rabello Oliveira M, da Rocha Ataìde T, de Oliveira S et al (2008) Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats. Neurosci Lett 434:66–70CrossRefPubMedGoogle Scholar
  14. 14.
    Yudkoff M, Daikhin Y, Horyn O, Nissim I (2008) Ketosis and brain handling of glutamate, glutamine, and GABA. Epilepsia 8:73–75CrossRefGoogle Scholar
  15. 15.
    Waeber C, Moskowitz MA (2005) Migraine as an inflammatory disorder. Neurology 64:S9–S15CrossRefPubMedGoogle Scholar
  16. 16.
    Jeong EA, Jeon BT, Shin HJ et al (2011) Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures. Exp Neurol 232(2):195–202CrossRefPubMedGoogle Scholar
  17. 17.
    Borkum JM (2016) Migraine triggers and oxidative stress: a narrative review and synthesis. Headache 56(1):12–35CrossRefPubMedGoogle Scholar
  18. 18.
    Kim D, Davis L, Sullivan P et al (2007) Ketone bodies are protective against oxidative stress in neocortical neurons. J Neurochem 101:1316–1326CrossRefPubMedGoogle Scholar
  19. 19.
    Maalouf M, Sullivan P, Davis L et al (2007) Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 145:256–264CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Bough K, Wetherington J, Hassel B et al (2006) Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 60:223–235CrossRefPubMedGoogle Scholar
  21. 21.
    Schnabel TG (1928) An experience with a ketogenic dietary in migraine. Ann Intern Med 2:341–347CrossRefGoogle Scholar
  22. 22.
    Strahlman RS (2006) Can ketosis help migraine sufferers? Headache 46:182CrossRefPubMedGoogle Scholar
  23. 23.
    Urbizu A, Cuenca-León E, Raspall-Chaure M et al (2010) Paroxysmal exercise-induced dyskinesia, writer’s cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation. J Neurol Sci 295(1–2):110–113CrossRefPubMedGoogle Scholar
  24. 24.
    Di Lorenzo C, Currà A, Sirianni G et al (2013) Diet transiently improves migraine in twin sisters: possible role of ketogenesis? Funct Neurol 28(4):305–308PubMedGoogle Scholar
  25. 25.
    Kossoff EH, Huffman J, Turner Z, Gladstein J (2010) Use of the modified Atkins diet for adolescents with chronic daily headache. Cephalalgia 30(8):1014–1016PubMedGoogle Scholar
  26. 26.
    Di Lorenzo C, Coppola G, Sirianni G et al (2015) Migraine improvement during short lasting ketogenesis: a proof-of-concept study. Eur J Neurol 22(1):170–177CrossRefPubMedGoogle Scholar
  27. 27.
    Di Lorenzo C, Coppola G, Bracaglia M et al (2016) Cortical functional correlates of responsiveness to short-lasting preventive intervention with ketogenic diet in migraine: a multimodal evoked potentials study. J Headache Pain 17:58. doi: 10.1186/s10194-016-0650-9 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Italia 2017

Authors and Affiliations

  • Piero Barbanti
    • 1
  • Luisa Fofi
    • 1
  • Cinzia Aurilia
    • 1
  • Gabriella Egeo
    • 1
  • Massimiliano Caprio
    • 2
    • 3
  1. 1.Headache and Pain Unit, Department of Neurological, Motor and Sensorial SciencesIRCCS San Raffaele PisanaRomeItaly
  2. 2.Laboratory of Cardiovascular EndocrinologyIRCCS San Raffaele PisanaRomeItaly
  3. 3.Department of Human Sciences and Promotion of the Quality of LifeSan Raffaele Roma Open UniversityRomeItaly

Personalised recommendations